Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction
Albert L. Waldo(Case Western Reserve University), Enrico P. Veltri(United States Nuclear Regulatory Commission), Hans deRuyter(Bristol-Myers Squibb (Germany)), Bertram Pitt(Bayer (Germany)), John F. Pauls(Bristol-Myers Squibb (Germany)), Daniel J. MacNeil(Bristol-Myers Squibb (Germany)), Craig M. Pratt(Baylor College of Medicine), A. John Camm(St George's, University of London), Peter L. Friedman(Harvard University), Peter J. Schwartz(Policlinico San Matteo Fondazione)
Cited by 1,374
Related Papers
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|Survey of Anesthesiology|2000|2.9k
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2020|2.6k
The Seattle Heart Failure Model
|Circulation|2006|2k